Executive Moves – BioTuesdays

Executive Moves

Jim Lilly joins England & Co. in healthcare investment banking

Jim Lilly joined England & Co., a middle-market investment bank, as a managing director in its New York office. Mr. Lilly brings more than 30 years of experience as a strategic advisor to a wide variety of...

January 19, 2021

Executive Moves

Justin Zelin joins BTIG as biotech analyst

BTIG has expanded its healthcare research coverage, adding Justin Zelin to its research and strategy division as a director. His biotech research coverage will include cell therapy, targeted oncology, immunology and...

January 15, 2021

Executive Moves

IntelGenx names Tommy Kenny as VP of intellectual property and legal affairs, general counsel

IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) appointed Tommy Kenny as VP intellectual property and legal affairs, general counsel of IntelGenx Corp., the company’s operating subsidiary. Mr. Kenny has been with...

January 13, 2021

Executive Moves

Fibrocor Therapeutics names biotech veteran Joseph Walewicz as CFO

Closely-held Fibrocor Therapeutics appointed Joseph Walewicz, a biotech veteran with more than 25 years of experience in finance, capital markets and business development, as CFO. Prior to joining Fibrocor, Mr. Walewicz...

January 7, 2021

Executive Moves

iBio names renowned drug discovery and development expert Martin Brenner as CSO

iBio (NYSE American:IBIO) appointed Martin Brenner, Doctor of Veterinary Medicine, Ph.D., as chief scientific officer, effective Jan. 18, 2021. Dr. Brenner has a strong history of success heading drug discovery and...

December 28, 2020

Executive Moves

PDS Biotechnology names Seth Van Voorhees as CFO

PDS Biotechnology (NASDAQ:PDSB) appointed Seth Van Voorhees, Ph.D., as its new CFO, effective Jan. 1, 2021. He replaces Michael King, who served as interim CFO. Dr. Van Voorhees most recently was CFO of Research...

December 9, 2020

Executive Moves

Benjamin Bowen joins Roth’s healthcare investment banking team

Benjamin Bowen, Ph.D., has joined Roth Capital Partners as managing director, healthcare investment banking. Prior to joining Roth, Dr. Bowen most recently was managing director in the investment banking group at...

December 4, 2020

Executive Moves

Profound Medical appoints accomplished financial executive, Murielle Lortie, to board

Profound Medical (NASDAQ:PROF; TSX:PRN) appointed financial executive, Murielle Lortie, as a director, effective immediately. Ms. Lortie is the CFO of Liminal Biosciences, a Nasdaq-listed, clinical-stage...

November 30, 2020

Executive Moves

ObsEva names Brian O’Callaghan as CEO

ObsEva (NASDAQ:OBSV) appointed Brian O’Callaghan as CEO, effective Dec. 1. He succeeds ObsEva’s co-founder, Ernest Loumaye, M.D., Ph.D., who is retiring from his role as CEO but will remain a director of the company. Mr...

November 9, 2020

Executive Moves

Marizyme names Neil Campbell as president and CEO

Marizyme (NASDAQ:MRZM) appointed Neil Campbell, Ph.D., as CEO, replacing executive chairman James Sapirstein, who has been the company’s interim CEO since September 2020. Dr. Campbell currently serves as chairman of...

November 6, 2020

Executive Moves

LogicBio names Mariana Nacht as CSO; Kyle Chiang as COO

LogicBio Therapeutics (NASDAQ:LOGC) appointed Mariana Nacht, Ph.D., as CSO, effective Nov. 30; and promoted Kyle Chiang, Ph.D., to the role of COO, effective Nov. 2. The company is expanding its leadership team to...

November 3, 2020

Executive Moves

Aethlon Medical names Charles Fisher as CEO

Aethlon Medical (NASDAQ:AEMD) appointed Charles Fisher, M.D., as CEO, effective Oct. 30. Dr. Fisher joined Aethlon as a member of its board and served as its chairman since November 2017. He succeeds Dr. Timothy Rodell...

November 3, 2020

Executive Moves

iBio appoints global biotech operations expert, Randy Maddux, as COO

iBio (NYSE AMERICAN:IBIO) appointed biotech industry veteran, Randy Maddux, as COO, effective Dec. 1. Mr. Maddux has more than 20 years of global biologics drug development and manufacturing, business development and...

November 3, 2020

Executive Moves

Soliton appoints Brad Hauser as president, CEO

Soliton (NASDAQ:SOLY) named Brad Hauser as president and CEO as the company prepares for its commercial launch. Mr. Hauser most recently was VP of R&D and general manager for CoolSculpting at Allergan Aesthetics, an...

November 2, 2020

Executive Moves

Fibrocor names William Fanslow as SVP drug development

Closely-held Fibrocor Therapeutics appointed industry veteran, William Fanslow Ph.D., as SVP of drug development. Dr. Fanslow has more than 20 years of experience in drug development, including both small molecules and...

October 26, 2020

Executive Moves

Perimeter Medical Imaging AI names Jeremy Sobotta as CEO; Tom Boon as COO

Perimeter Medical Imaging AI (TSXV:PINK; FSE:4PC) appointed Jeremy Sobotta as its new CEO and Tom Boon as its new COO, effective immediately. Mr. Sobotta was most recently Perimeter’s CFO and replaces Tom Boon as CEO...

October 22, 2020

Executive Moves

iBio appoints accomplished financial executive, Gary Sender, to board

iBio (NYSE AMERICAN:IBIO) appointed senior financial executive, Gary Sender, as a director and a member of the board’s compensation committee. In addition, Mr. Sender was appointed chair of iBio’s audit committee...

October 15, 2020

Executive Moves

iBio appoints senior biopharma executive, Dr. Alexandra Kropotova, to board

iBio (NYSE AMERICAN:IBIO) appointed senior biopharma executive, Dr. Alexandra Kropotova, as a director and a member of the board’s new science and technology committee. Dr. Kropotova has expertise in all phases of...

October 15, 2020

Executive Moves

iBio appoints renowned biopharma executive, Dr. Linda Armstrong, to board

iBio (NYSE AMERICAN:IBIO) appointed Dr. Linda Armstrong, a renowned biopharma executive, as a director and a member of the board’s new science and technology committee. “We are pleased to welcome Dr. Armstrong to our...

October 14, 2020

Executive Moves

Long-time biotech analyst Doug Loe joins Leede Jones Gable

Doug Loe, Ph.D. has joined Leede Jones Gable as it continues to grow its capital markets team, boosting healthcare and biotechnology, and building on recent additions in sales and trading. Dr. Loe, who brings more than...

October 14, 2020

Executive Moves

Kaleido Biosciences names Daniel Menichella as president and CEO

Kaleido Biosciences (NASDAQ:KLDO) appointed Daniel Menichella as president and CEO, effective Oct. 13. Mr. Menichella will replace Alison Lawton, who is stepping down for personal reasons. Mr. Menichella is an...

October 1, 2020

Executive Moves

PharmaJet appoints Melissa Malhame as VP business development

Closely-held PharmaJet appointed Melissa Malhame as its VP of business development, where she will lead the company’s business development, sales, and marketing operations. “[Ms. Malhame’s] strategic business...

September 29, 2020

Jim Lilly joins England & Co. in healthcare investment banking

Justin Zelin joins BTIG as biotech analyst

IntelGenx names Tommy Kenny as VP of intellectual property and legal affairs, general counsel

Fibrocor Therapeutics names biotech veteran Joseph Walewicz as CFO

iBio names renowned drug discovery and development expert Martin Brenner as CSO

PDS Biotechnology names Seth Van Voorhees as CFO

Benjamin Bowen joins Roth’s healthcare investment banking team

Profound Medical appoints accomplished financial executive, Murielle Lortie, to board

ObsEva names Brian O’Callaghan as CEO

Marizyme names Neil Campbell as president and CEO

LogicBio names Mariana Nacht as CSO; Kyle Chiang as COO

Aethlon Medical names Charles Fisher as CEO

iBio appoints global biotech operations expert, Randy Maddux, as COO

Soliton appoints Brad Hauser as president, CEO

Fibrocor names William Fanslow as SVP drug development

Perimeter Medical Imaging AI names Jeremy Sobotta as CEO; Tom Boon as COO

iBio appoints accomplished financial executive, Gary Sender, to board

iBio appoints senior biopharma executive, Dr. Alexandra Kropotova, to board

iBio appoints renowned biopharma executive, Dr. Linda Armstrong, to board

Long-time biotech analyst Doug Loe joins Leede Jones Gable

Kaleido Biosciences names Daniel Menichella as president and CEO

PharmaJet appoints Melissa Malhame as VP business development

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter